A detailed history of Essex Woodlands Management, Inc. transactions in Bioventus Inc. stock. As of the latest transaction made, Essex Woodlands Management, Inc. holds 13,021,324 shares of BVS stock, worth $139 Million. This represents 44.65% of its overall portfolio holdings.

Number of Shares
13,021,324
Previous 13,021,324 -0.0%
Holding current value
$139 Million
Previous $74.9 Million 107.83%
% of portfolio
44.65%
Previous 24.48%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$0.93 - $3.64 $859,898 - $3.37 Million
924,622 Added 7.64%
13,021,324 $37.6 Million
Q1 2021

May 14, 2021

BUY
$11.49 - $19.21 $139 Million - $232 Million
12,096,702 New
12,096,702 $185 Million

Others Institutions Holding BVS

About Bioventus Inc.


  • Ticker BVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 61,664,200
  • Market Cap $658M
  • Description
  • Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...
More about BVS
Track This Portfolio

Track Essex Woodlands Management, Inc. Portfolio

Follow Essex Woodlands Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex Woodlands Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Essex Woodlands Management, Inc. with notifications on news.